110 related articles for article (PubMed ID: 3733320)
21. Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
Cheng W; Lim LY
Mol Pharm; 2008; 5(4):610-21. PubMed ID: 18481870
[TBL] [Abstract][Full Text] [Related]
22. Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution.
Amodeo P; Motta A; Strazzullo G; Castiglione Morelli MA
J Biomol NMR; 1999 Feb; 13(2):161-74. PubMed ID: 10070757
[TBL] [Abstract][Full Text] [Related]
23. Study of a series of analogs of salmon calcitonin in which alanine replaces leucine.
Epand RM; Epand RF; Orlowski RC
Eur J Biochem; 1990 Mar; 188(3):633-5. PubMed ID: 2331988
[TBL] [Abstract][Full Text] [Related]
24. Exploring the conformational roles of signal sequences: synthesis and conformational analysis of lambda receptor protein wild-type and mutant signal peptides.
Briggs MS; Gierasch LM
Biochemistry; 1984 Jul; 23(14):3111-4. PubMed ID: 6380582
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a synthetic peptide corresponding to a receptor binding domain of mouse interferon gamma.
Magazine HI; Johnson HM
Biochemistry; 1991 Jun; 30(23):5784-9. PubMed ID: 1828370
[TBL] [Abstract][Full Text] [Related]
26. Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure.
Orlowski RC; Epand RM; Stafford AR
Eur J Biochem; 1987 Jan; 162(2):399-402. PubMed ID: 3803393
[TBL] [Abstract][Full Text] [Related]
27. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
Zhu HL; Atkinson D
Biochemistry; 2004 Oct; 43(41):13156-64. PubMed ID: 15476409
[TBL] [Abstract][Full Text] [Related]
28. Platypus and opossum calcitonins exhibit strong activities, even though they belong to mammals.
Yamashita T; Udagawa N; Thirukonda GJ; Uehara S; Yamauchi H; Suzuki N; Li F; Kobayashi Y; Takahashi N
Gen Comp Endocrinol; 2017 May; 246():270-278. PubMed ID: 28062306
[TBL] [Abstract][Full Text] [Related]
29. Structural characterization and topology of the second potential membrane anchor region in the thromboxane A2 synthase amino-terminal domain.
Ruan KH; Li D; Ji J; Lin YZ; Gao X
Biochemistry; 1998 Jan; 37(3):822-30. PubMed ID: 9454571
[TBL] [Abstract][Full Text] [Related]
30. Structural and binding characteristics of the carboxyl terminal fragment of apolipophorin III from Manduca sexta.
Narayanaswami V; Kay CM; Oikawa K; Ryan RO
Biochemistry; 1994 Nov; 33(45):13312-20. PubMed ID: 7947739
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and characterization of a model peptide having potent calcitonin-like biological activity: implications for calcitonin structure/activity.
Moe GR; Kaiser ET
Biochemistry; 1985 Apr; 24(8):1971-6. PubMed ID: 2990546
[TBL] [Abstract][Full Text] [Related]
32. Conformation of the alpha form of human calcitonin gene-related peptide (CGRP) in aqueous solution as determined by circular dichroism spectroscopy.
Manning MC
Biochem Biophys Res Commun; 1989 Apr; 160(1):388-92. PubMed ID: 2785388
[TBL] [Abstract][Full Text] [Related]
33. Sequential 1H NMR assignment and secondary structure determination of salmon calcitonin in solution.
Motta A; Morelli MA; Goud N; Temussi PA
Biochemistry; 1989 Oct; 28(20):7996-8002. PubMed ID: 2605169
[TBL] [Abstract][Full Text] [Related]
34. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs.
Rawat A; Kumar D
J Pept Sci; 2013 Jan; 19(1):33-45. PubMed ID: 23208874
[TBL] [Abstract][Full Text] [Related]
35. Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-II.
Benetollo C; Lambert G; Talussot C; Vanloo E; Cauteren TV; Rouy D; Dubois H; Baert J; Kalopissis A; Denèfle P; Chambaz J; Brasseur R; Rosseneu M
Eur J Biochem; 1996 Dec; 242(3):657-64. PubMed ID: 9022694
[TBL] [Abstract][Full Text] [Related]
36. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.
Kapurniotu A; Taylor JW
J Med Chem; 1995 Mar; 38(5):836-47. PubMed ID: 7877149
[TBL] [Abstract][Full Text] [Related]
37. Influence of helix formation on cis/trans isomerism of Xaa-Pro bonds flanking the helical segment.
Meyer S; Drewello M; Fischer G
Biol Chem; 1996; 377(7-8):489-95. PubMed ID: 8922283
[TBL] [Abstract][Full Text] [Related]
38. Analogue separates biological effects of salmon calcitonin on brain and renal cortical membranes.
Twery MJ; Seitz PK; Nickols GA; Cooper CW; Gallagher JP; Orlowski RC
Eur J Pharmacol; 1988 Oct; 155(3):285-92. PubMed ID: 3266153
[TBL] [Abstract][Full Text] [Related]
39. Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices.
Zhou NE; Mant CT; Hodges RS
Pept Res; 1990; 3(1):8-20. PubMed ID: 2134049
[TBL] [Abstract][Full Text] [Related]
40. Conformation studies of biologically active fragments of bovine growth hormone.
Hsu Chen CJ; Sonenberg M
Biochemistry; 1977 May; 16(10):2110-8. PubMed ID: 558794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
